ABBVIE BIOTECH VENTURES
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
ABBVIE BIOTECH VENTURES
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apache COVID-19 Google Optimize 360 Amazon Elastic Load Balancing Sticky Session Amazon ALB SEO_H2 Adobe Experience Manager
Similar Organizations
BlueStone Venture Partners
BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-06 | AmbAgon Therapeutics | AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-11-02 | Nitrase Therapeutics | AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics | 7 M USD |
| 2021-10-26 | Quanta Therapeutics | AbbVie Biotech Ventures investment in Series C - Quanta Therapeutics | 60 M USD |
| 2021-08-18 | Jnana Therapeutics | AbbVie Biotech Ventures investment in Series B - Jnana Therapeutics | 50 M USD |
| 2021-08-17 | Starday Foods | AbbVie Biotech Ventures investment in Seed Round - Starday Foods | 4 M USD |
| 2021-07-15 | Stemson Therapeutics | AbbVie Biotech Ventures investment in Series A - Stemson Therapeutics | 15 M USD |
| 2021-06-14 | Ribon Therapeutics | AbbVie Biotech Ventures investment in Series C - Ribon Therapeutics | 65 M USD |
| 2021-03-03 | Caribou Biosciences | AbbVie Biotech Ventures investment in Series C - Caribou Biosciences | 115 M USD |
| 2021-03-01 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 47 M USD |
More informations about "AbbVie Biotech Ventures" on Search Engine
AbbVie Ventures | AbbVie
May 7, 2024 Investing since 2009, we focus exclusively on novel, transformational therapeutics at discovery and pre-clinical stages. Aligning with AbbVie’s strategic focus, …See details»
AbbVie Biotech Ventures - Crunchbase Investor Profile
AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies. North Chicago, Illinois, United States. 1-10. …See details»
AbbVie Ventures Portfolio | AbbVie - Pharmaceutical Research
Partner with Us. AbbVie Ventures. Portfolio. AbbVie Ventures is focused on early-stage opportunities in oncology, immunology, neuroscience, eye care, and aesthetics. Active …See details»
Partner with Us | AbbVie
May 7, 2024 AbbVie Ventures. We strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation …See details»
AbbVie Biotech Ventures - Investments, Portfolio & Company Exits
About. AbbVie Biotech Ventures has made 51 investments. Their most recent investment was on Jan 23, 2024, when Accent Therapeutics raised. $75M. AbbVie Biotech …See details»
AbbVie Biotech Ventures Portfolio Companies - Crunchbase
AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies. This list of organizations invested in by AbbVie …See details»
AbbVie Completes Acquisition of ImmunoGen - Feb 12, 2024
NORTH CHICAGO, Ill., Feb. 12, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of ImmunoGen (NASDAQ: IMGN). With the …See details»
AbbVie News Center - News
Aug 12, 2021 AbbVie will grant AIM awards for up to two early-stage biotech companies. Each AIM award includes the opportunity to receive seed funding from AbbVie …See details»
AbbieVie Ventures » LaunchBio event
March 28, 2024. 2-3:30pm ET, 11-12:30am PT. Online. AbbieVie Ventures. Focus on therapeutic companies. Program. Calling all early-stage biotech and novel therapeutics …See details»
Shann Yu, PhD (楊凱文) - Associate Director
Biotech VC | Corporate Strategy @ AbbVie · I have a passion for improving human health and lives through biomedical innovation, which I bring to …See details»
AbbVie and Anima Biotech Announce Collaboration for the …
Back to All News. January 10, 2023. AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and …See details»
AbbVie links up with VC firm to map anti-inflammatory companies
By James Waldron Nov 28, 2022 7:30am. AbbVie anti-inflammatory venture capital (VC) inflammatory diseases. Deep Science Ventures' partnership with AbbVie is “a statement …See details»
AbbVie Biotech Ventures - Updates, News, Events, Signals
Mar 28, 2024 Powered by AI. AbbVie Biotech Ventures focuses on early to mid-stage investments in companies that are primarily within the biotechnology and healthcare …See details»
abbvie
Our goal is to create long-term, mutually beneficial relationships to discover and deliver innovative medicines and solutions that address complex health issues and enhance …See details»
A decade of making a meaningful impact in Canada - abbvie.ca
Over the last decade, AbbVie’s science, innovation, and ability to make new therapies available for people with the greatest need has helped to advance standards of care for …See details»
AbbVie inks $2B-plus next-gen neuro deal with Gilgamesh
5 days ago AbbVie has inked a new deal with Gilgamesh Pharmaceuticals aimed at developing next-gen therapies for psychiatric disorders.. The two companies have …See details»
Our Leaders | AbbVie
May 7, 2024 Our Leaders. Our mission to improve lives starts at the top. Richard A. Gonzalez. Chairman of the Board and Chief Executive Officer. Meet Rick. Robert A. …See details»
AbbVie - Wikipedia
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, …See details»
AbbVie - Crunchbase Company Profile & Funding
Details. Industries. Biotechnology. Health Care. Medical. Pharmaceutical. Headquarters Regions Greater Chicago Area, Great Lakes, Midwestern US. Founded Date 2013. …See details»
AbbVie Expands Biologics Manufacturing Capacity with a $223 …
SINGAPORE Jan. 26, 2024 – AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) …See details»